Table 7.
No. | Activity reviewed | Activities confirmed (Pa) | Additional predicted activities (Paa) |
---|---|---|---|
98 | Cytotoxic | Antineoplastic (0.730) | Antiprotozoal (plasmodium) (0.641) Antiprotozoal (0.579) |
99 | Immunosuppressant | – | β-1,3-galactosyl-O-glycosyl-glycoprotein β-1,6-N-acetylglucosaminyl transferase inhibitor (0.954) Antineoplastic (0.609) |
100 | Not studied | – | Neurodegenerative diseases treatment (0.920) Antiparkinsonian (0.900) Anxiolytic (0.796) |
101 | Not studied | – | Acaricide (0.721) Antiviral (arbovirus) (0.681) |
102 | Not studied | – | Not predicted: MolCharge: 1 |
103 | Not studied | – | Not predicted: MolCharge: 1 |
104 | Not studied | – | Antiinfertility, female (0.940) Antineoplastic(0.835) Phobic disorders treatment (0.726) |
105 | Toxic carcinogenic mutagenic neurotoxic | Carcinogenic (0.975) Toxic (0.932) Neurotoxic (0.746) |
Embryotoxic (0.957) Teratogen (0.952) Hepatotoxic (0.716) |
106 | Toxic carcinogenic mutagenic neurotoxic | Carcinogenic (0.975) Toxic (0.932) Eurotoxic (0.746) |
Embryotoxic (0.957) Teratogen (0.952) Hepatotoxic (0.716) |
107 | Not studied | – | Antineoplastic (0.892) Genital warts treatment (0.870) Antiinfective (0.837) |
108 | Toxic carcinogenic mutagenic neurotoxic | Carcinogenic (0.964) Toxic (0.943) Neurotoxic (0.822) |
Embryotoxic (0.960) Teratogen (0.950) Hematotoxic (0.695) |
109 | Not studied | – | Genital warts treatment (0.876) Antineoplastic (0.866) Vasoprotector (0.851) |
110 | Not studied | – | Antineoplastic (0.892) Genital warts treatment (0.870) Antiinfective (0.837) |
111 | Not studied | – | Antineoplastic (0.892) Genital warts treatment (0.870) Antiinfective (0.837) |
112 | Not studied | – | Antineoplastic (0.897) Genital warts treatment (0.870) Antiinfective (0.837) |
113 | Not studied | – | Antineoplastic (0.889) Genital warts treatment (0.857) Vasoprotector (0.828) |
114 | Not studied | – | Antineoplastic (0.889) Genital warts treatment (0.857) Vasoprotector (0.828) |
115 | Not studied | – | Antineoplastic (0.900) Genital warts treatment (0.864) Hepatic disorders treatment (0.791) |
116 | Not studied | – | Antineoplastic (0.889) Genital warts treatment (0.857) Vasoprotector (0.828) |
117 | Not studied | – | Antineoplastic (0.889) Genital warts treatment (0.842) Hepatic disorders treatment (0.810) |
aOnly activities with Pa > 0.5 are shown